Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis

被引:172
作者
Carroll, Patrick A. [1 ]
Diolaiti, Daniel [1 ]
McFerrin, Lisa [1 ]
Gu, Haiwei [2 ]
Djukovic, Danijel [2 ]
Du, Jianhai [4 ]
Cheng, Pei Feng [1 ]
Anderson, Sarah [1 ]
Ulrich, Michelle [1 ]
Hurley, James B. [4 ,5 ]
Raftery, Daniel [2 ,3 ]
Ayer, Donald E. [6 ]
Eisenman, Robert N. [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA
[2] Univ Washington, Dept Anesthesiol & Pain Med, Northwest Metabol Res Ctr, Seattle, WA 98109 USA
[3] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[4] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[5] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA
[6] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA
关键词
C-MYC; CELL-PROLIFERATION; GLUTAMINE; NEUROBLASTOMA; MAX; EXPRESSION; MLX; INDUCTION; APOPTOSIS; PROTEIN;
D O I
10.1016/j.ccell.2014.11.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Deregulated Myc transcriptionally reprograms cell metabolism to promote neoplasia. Here we show that oncogenic Myc requires the Myc superiamily member MondoA, a nutrient-sensing transcription factor, for tumorigenesis. Knockdown of MondoA, or its dimerization partner Mlx, blocks Myc-induced reprogramming of multiple metabolic pathways, resulting in apoptosis. Identification and knockdown of genes coregulated by Myc and MondoA have allowed us to define metabolic functions required by deregulated Myc and demonstrate a critical role for lipid biosynthesis in survival of Myc-driven cancer. Furthermore, overexpression of a subset of Myc and MondoA coregulated genes correlates with poor outcome of patients with diverse cancers. Coregulation of cancer metabolism by Myc and MondoA provides the potential for therapeutics aimed at inhibiting MondoA and its target genes.
引用
收藏
页码:271 / 285
页数:15
相关论文
共 63 条
[1]   Reverse engineering of regulatory networks in human B cells [J].
Basso, K ;
Margolin, AA ;
Stolovitzky, G ;
Klein, U ;
Dalla-Favera, R ;
Califano, A .
NATURE GENETICS, 2005, 37 (04) :382-390
[2]  
Billin AN, 2006, CURR TOP MICROBIOL, V302, P255
[3]   Mix, a novel max-like BHLHZip protein that interacts with the max network of transcription factors [J].
Billin, AN ;
Eilers, AL ;
Queva, C ;
Ayer, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36344-36350
[4]   Neuroblastoma: Biological insights into a clinical enigma [J].
Brodeur, GM .
NATURE REVIEWS CANCER, 2003, 3 (03) :203-216
[5]   An Overview of MYC and Its Interactome [J].
Conacci-Sorrell, Maralice ;
McFerrin, Lisa ;
Eisenman, Robert N. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2014, 4 (01)
[6]   Therapeutic Targeting of Myc-Reprogrammed Cancer Cell Metabolism [J].
Dang, C. V. .
METABOLISM AND DISEASE, 2011, 76 :369-374
[7]   MYC, Metabolism, Cell Growth, and Tumorigenesis [J].
Dang, Chi V. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2013, 3 (08)
[8]   MYC on the Path to Cancer [J].
Dang, Chi V. .
CELL, 2012, 149 (01) :22-35
[9]  
Diolaiti D, 2014, BIOCH BIOPHYS ACTA
[10]   Cytosolic reducing power preserves glutamate in retina [J].
Du, Jianhai ;
Cleghorn, Whitney ;
Contreras, Laura ;
Linton, Jonathan D. ;
Chan, Guy C. -K. ;
Chertov, Andrei O. ;
Saheki, Takeyori ;
Govindaraju, Viren ;
Sadilek, Martin ;
Satrustegui, Jorgina ;
Hurley, James B. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (46) :18501-18506